Dulaglutide: Benefits and Side Effects in 2025
Dulaglutide is a once-weekly GLP-1 receptor agonist used for managing type 2 diabetes and supporting weight loss. As of 2025, its use continues to expand globally due to its ability to regulate blood sugar levels and promote satiety, making it a dual-action solution for diabetic and obese patients.
Unlike daily injections, Dulaglutide requires just one shot per week, increasing patient compliance. Common benefits include improved A1C, reduced appetite, and potential cardiovascular protection. However, side effects such as nausea, fatigue, and possible thyroid issues should be monitored closely, especially during the initial treatment phase.
Dulaglutide competes with other GLP-1 drugs like Ozempic and Mounjaro, offering comparable glycemic control. For a broader comparison of options, explore our guide on Top GLP-1 Drugs for Diabetes and Obesity.
In 2025, Dulaglutide remains a reliable therapy for those needing both metabolic control and gradual weight reduction, especially in patients with cardiovascular risk factors.